Lupin Manufacturing Solutions Unveils Dedicated Oncology Block at Vizag, India

Lupin Manufacturing Solutions (LMS), a subsidiary of global pharma major Lupin Limited, has commissioned a dedicated Oncology Block at its Vizag facility in India. The new high-containment unit significantly enhances LMS’s end-to-end Contract Development and Manufacturing capabilities for High Potent Active Pharmaceutical Ingredients (HPAPIs). The facility, equipped with advanced containment systems, ensures exposure levels of <0.05 ug/m3 and allows for safe, efficient, and compliant production of oncology APIs that meet global quality standards. The new block integrates the Process Development Laboratory with a dedicated Quality Control laboratory, enabling early-stage route scouting, analytical development, process optimization, and validation. With this expansion, LMS strengthens its role as a trusted global CDMO partner for oncology innovators.